IM Cannabis (IMCC) Profit After Tax (2020 - 2026)
IM Cannabis' (IMCC) quarterly Profit After Tax came in at -$1.8 million in Q1 2026, down 1575.03% year-on-year from $121960.4 in Q1 2025, and up 83.88% quarter-over-quarter from -$11.2 million in Q4 2025.
IM Cannabis (IMCC) Profit After Tax (2020 - 2026) Analysis & Trends
IM Cannabis' Profit After Tax history runs 7 years deep, the most recent figure standing at -$1.8 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 1575.03% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$11.4 million, a 37.62% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 2.0% from the prior year.
- Profit After Tax advanced to -$1.8 million in Q1 2026 per IMCC's latest filing, from -$11.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $9.2 million in Q1 2022 and bottomed at -$15.3 million in Q4 2024.
- The 5-year median for Profit After Tax is -$2.4 million (2024), against an average of -$3.2 million.
- Across the five-year window, Profit After Tax jumped 492.52% in 2025 and sank 1575.03% in 2026, its largest moves.
- Year by year, Profit After Tax stood at -$7.1 million in 2022, then sank by 74.58% to -$12.4 million in 2023, then dropped by 23.1% to -$15.3 million in 2024, then advanced by 26.98% to -$11.2 million in 2025, then jumped by 83.88% to -$1.8 million in 2026.
- Per Business Quant, the three latest IMCC Profit After Tax figures stand at -$1.8 million (Q1 2026), -$11.2 million (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.80 Mn |
| Dec 31, 2025 | -11.16 Mn |
| Sep 30, 2025 | 2.65 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | 121,960.38 |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -675,875.24 |
| Jun 30, 2024 | -2.38 Mn |
| Mar 31, 2024 | -4.47 Mn |
| Dec 31, 2023 | -12.41 Mn |
| Sep 30, 2023 | -1.45 Mn |
| Jun 30, 2023 | -2.60 Mn |
| Mar 31, 2023 | 915,004.40 |
| Dec 31, 2022 | -7.11 Mn |
| Sep 30, 2022 | -3.47 Mn |
| Jun 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | 9.22 Mn |
| Dec 31, 2021 | -19.52 Mn |
| Sep 30, 2021 | -3.76 Mn |
| Jun 30, 2021 | 3.99 Mn |